Rethinking Cancer Drug Doses
Cancer Today,
Forward Look Researchers and patients push to move away from maximum tolerated dose in research.
Most Oncology Patients Interested in Flexible Dosing
Medscape,
This transcript has been edited for clarity. Hello. I'm Dr Maurie Markman, from City of Hope.
FDA Finalizes Guidance On Dose Optimization For Oncology Therapies
Clinical Leader,
By Marjorie Zettler, Ph.D., MPH, senior director, clinical science, Accutar Biotech A survey of over 1,000 patients with…
A pedido de los sobrevivientes, los investigadores revalúan las dosis de los medicamentos del cáncer
National Cancer Institute,
1 de agosto de 2024, por Linda Wang A fin de disminuir los efectos secundarios relacionados con el tratamiento, más…